3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Brain Neoplasms
4
Pancreatic Neoplasms
3
Glioblastoma
3
Sarcoma
2
Neoplasms
2
Lung Neoplasms
2
Gliosarcoma
2
Glioma
2
Urothelial Carcinoma of the Bladder
1
Thoracic Neoplasms
1
Stage IA-IIA Breast Cancer
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Resected Pancreatic Adenocarcinoma
1
Recurrence
1
Pinealoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Gastrointestinal Neoplasms
1
Eye Neoplasms
1
Esophageal Neoplasms
1
Ependymoma
1
Desmoplastic Small Round Cell Tumor
1
Chordoma
1
Chondrosarcoma
1
Interventions
Carboplatin
23
Cisplatin
19
pembrolizumab
14
Paclitaxel
12
Gemcitabine
12
Pemetrexed
11
130-nm albumin-bound paclitaxel
9
Everolimus
8
Cetuximab
8
Fluorouracil
7
Axitinib
6
osimertinib
5
durvalumab
5
Sunitinib
5
Radiotherapy
5
Erlotinib Hydrochloride
5
Docetaxel
5
Cyclophosphamide
5
Albumin-Bound Paclitaxel
5
Sorafenib
4
Radiation
4
Nivolumab
4
Ipilimumab
4
vosaroxin
3
Radiotherapy, Intensity-Modulated
3
Octreotide
3
Irinotecan
3
Bevacizumab
3
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
3
pralsetinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma
×
Proton Therapy
×
Clear all
No trials found.